Wealthedge Investment Advisors »

Relmada Therapeutics shares owned by Wealthedge Investment Advisors

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Wealthedge Investment Advisors from 13F filings

Historical chart of Wealthedge Investment Advisors investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Wealthedge Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Wealthedge Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $17k 28k 0.60
2025-03-31 $7.6k 28k 0.27
2024-12-31 $15k 28k 0.52

More positions owned by Wealthedge Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Microsoft Corporation (MSFT)
Agf Invts Tr Us Market Netrl (BTAL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHP)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Russell 2000 Etf (IWM)
Bristol Myers Squibb (BMY)

View all positions for Wealthedge Investment Advisors

Top funds holding Relmada Therapeutics

Ikarian Capital
Vanguard Group
Driehaus Capital Management
Boothbay Fund Management
Acadian Asset Management
BlackRock
AdvisorShares Investments
Geode Capital Management
Marshall Wace
Parsons Capital Management
Deutsche Bank Aktiengesellschaft
CI Private Wealth
Susquehanna International
Two Sigma Investments
Renaissance Technologies

View all funds holding Relmada Therapeutics